A nursing home management company has agreed to pay $2.7 million to the federal government to resolve a whistleblower lawsuit that alleged the company tried to defraud Medicare by submitting…
Amgen has agreed to pay $762 million to settle a whistleblower lawsuit and criminal charges this week, which allege that the drug maker illegally promoted their anemia medications Aranesp and…
In a decision that could fundamentally change the actions of the pharmaceutical industry in the United States, a federal appeals court has ruled that the government does not have the…
The federal government reports that it has collected nearly $5 billion through whistleblower lawsuits in 2012, with about $439 million of the money recovered paid to whistleblowers who brought the…
State and federal governments are reaching record settlements with pharmaceutical companies over claims involving fraudulent or illegal activity promoting prescription drugs, with more than $6 billion collected from the industry…
Federal prosecutors have decided to intervene in a whistleblower lawsuit filed against Vascular Solutions, which alleges that the company illegally marketed its Vari-Lase medical device for unapproved uses.
A machine heralded for literally melting body fat away appears to have been marketed illegal in the United States, leading to calls for the FDA to take immediate action to…
As a reward for blowing the whistle on illegal drug marketing practices at GlaxoSmithKline, four former employees will split an estimated $250 million dollars.
Drug maker GlaxoSmithKline has agreed to pay $3 billion to resolve federal criminal and civil charges stemming from the illegal marketing and promotion of some of their top selling medications,…
A whistleblower lawsuit accuses Takeda Pharmaceuticals of hiding potentially harmful side effects of Uloric, a gout medication.
